AA-31-YE07_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, Chrysin, Apoptosis Inducers;Breast Cancer-Resistant Protein (BCRP;Antiinflammatory Drugs;ABCG2) Inhibitors;Antioxidants targeting ABCG2, HSD17B10, HSD17B7, HSD17B2, HSD17B8, HSD17B6, HSD17B12, HSD17B11, HSD17B14, HSD17B13 (Novartis, 5281607)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/5281607
Similar Terms
Downloads & Tools

Genes

12 genes differentially expressed following the AA-31-YE07_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
SELENOW selenoprotein W 0.621307
TMSB10 thymosin beta 10 0.46483
MT1E metallothionein 1E 0.46483
C11ORF24 chromosome 11 open reading frame 24 0.257415
SLC25A21 solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 0.247318
RPS2 ribosomal protein S2 0.225882
CSRP1 cysteine and glycine-rich protein 1 0.213133

decreased expression

Symbol Name Standardized Value
MAGED1 melanoma antigen family D1 -0.621307
LAMTOR4 late endosomal/lysosomal adaptor, MAPK and MTOR activator 4 -0.257415
CCT7 chaperonin containing TCP1, subunit 7 (eta) -0.24846
RPS28 ribosomal protein S28 -0.215192
RPS3 ribosomal protein S3 -0.200641